| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Department of Neuroendocrinology, Max Planck Institute of Psychiatry, 80804 Munich, Germany;
Laboratory of General and Comparative Physiology, UMR CNRS 8572, Muséum National d’Histoire Naturelle, 75231 Paris, France; and
Department of Neurobiochemistry, Max Planck Institute of Neurobiology, 82152 Martinsried, Germany
1Correspondence: Max Planck Institute of Psychiatry, Kraepelinstrasse 2–10, D-80804 Munich, Germany. E-mail: osa{at}mpipsykl.mpg.de
Glucocorticoid receptor (GR) activation induces apoptosis of granule cells in the hippocampus. In contrast, neuroprotection is seen after mineralocorticoid receptor (MR) activation. To date there is no in vivo evidence for direct interactions between corticosteroids and any of the key regulatory molecules of programmed cell death. In this report, we show that the opposing actions of MR and GR on neuronal survival result from their ability to differentially influence the expression of members of the bcl-2 gene family; specifically, in the rat hippocampus, activation of GR induces cell death by increasing the ratio of the proapoptotic molecule Bax relative to the antiapoptotic molecules Bcl-2 or Bcl-xL; the opposite effect is observed after stimulation of MR. The same results were obtained in both young and aged animals; however, older subjects (which were more susceptible to GR-mediated apoptosis) tended to express the antiapoptotic genes more robustly. Using a loss-of-function mouse model, we corroborated the observations made in the rat, demonstrating Bax to be essential in the GR-mediated cell death-signaling cascade. In addition, we show that GR activation increases and MR activation decreases levels of the tumor suppressor protein p53 (a direct transcriptional regulator of bax and bcl-2 genes), thus providing new information on the early genetic events linking corticosteroid receptors with apoptosis in the nervous system.—Almeida, O. F. X., Condé, G. L., Crochemore, C., Demeneix, B. A., Fischer, D., Hassan, A. H. S., Meyer, M., Holsboer, F., Michaelidis, T. M. Subtle shifts in the ratio between pro- and antiapoptotic molecules after activation of corticosteroid receptors decide neuronal fate.
Key Words: apoptosis • Bcl-2 • Bax • bax knockout mouse • corticosterone • dexamethasone • mineralocorticoid receptor • glucocorticoid receptor
This article has been cited by other articles:
|
|
 |
|
  S. J. Spencer, M. A. Galic, M. Tsutsui, Q. J. Pittman, and A. Mouihate Effects of Global Cerebral Ischemia in the Pregnant Rat Stroke, March 1, 2008; 39(3): 975 - 982. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K J Rademaker, L S de Vries, C S P M Uiterwaal, F Groenendaal, D E Grobbee, and F van Bel Postnatal hydrocortisone treatment for chronic lung disease in the preterm newborn and long-term neurodevelopmental follow-up Arch. Dis. Child. Fetal Neonatal Ed., January 1, 2008; 93(1): F58 - F63. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Bianchini, G. Nocentini, L. T. Krausz, K. Fettucciari, S. Coaccioli, S. Ronchetti, and C. Riccardi Modulation of Pro- and Antiapoptotic Molecules in Double-Positive (CD4+CD8+) Thymocytes following Dexamethasone Treatment J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 887 - 897. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Sola, J. D. Amaral, P. M. Borralho, R. M. Ramalho, R. E. Castro, M. M. Aranha, C. J. Steer, and C. M. P. Rodrigues Functional Modulation of Nuclear Steroid Receptors by Tauroursodeoxycholic Acid Reduces Amyloid {beta}-Peptide-Induced Apoptosis Mol. Endocrinol., October 1, 2006; 20(10): 2292 - 2303. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Ranta, D. Avram, S. Berchtold, M. Dufer, G. Drews, F. Lang, and S. Ullrich Dexamethasone induces cell death in insulin-secreting cells, an effect reversed by exendin-4. Diabetes, May 1, 2006; 55(5): 1380 - 1390. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Schubert, G. Stoltenburg-Didinger, A. Wehsack, D. Troitzsch, W. Boettcher, M. Huebler, M. Redlin, M. Kanaan, M. Meissler, P. E. Lange, et al. Large-Dose Pretreatment with Methylprednisolone Fails to Attenuate Neuronal Injury After Deep Hypothermic Circulatory Arrest in a Neonatal Piglet Model Anesth. Analg., November 1, 2005; 101(5): 1311 - 1318. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Cerqueira, J. M. Pego, R. Taipa, J. M. Bessa, O. F. X. Almeida, and N. Sousa Morphological Correlates of Corticosteroid-Induced Changes in Prefrontal Cortex-Dependent Behaviors J. Neurosci., August 24, 2005; 25(34): 7792 - 7800. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Lu, Y. Wu, N. Sousa, and O. F. X. Almeida SMAD pathway mediation of BDNF and TGF{beta}2 regulation of proliferation and differentiation of hippocampal granule neurons Development, July 15, 2005; 132(14): 3231 - 3242. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. A. Lodygensky, K. Rademaker, S. Zimine, M. Gex-Fabry, A. F. Lieftink, F. Lazeyras, F. Groenendaal, L. S. de Vries, and P. S. Huppi Structural and Functional Brain Development After Hydrocortisone Treatment for Neonatal Chronic Lung Disease Pediatrics, July 1, 2005; 116(1): 1 - 7. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Volpe Encephalopathy of Prematurity Includes Neuronal Abnormalities Pediatrics, July 1, 2005; 116(1): 221 - 225. [Full Text] [PDF]
|
|
|
|
|
|
L. Pascual-Le Tallec, F. Simone, S. Viengchareun, G. Meduri, M. J. Thirman, and M. Lombes The Elongation Factor ELL (Eleven-Nineteen Lysine-Rich Leukemia) Is a Selective Coregulator for Steroid Receptor Functions Mol. Endocrinol., May 1, 2005; 19(5): 1158 - 1169. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. KITRAKI, O. KREMMYDA, D. YOULATOS, M. ALEXIS, and C. KITTAS Spatial Performance and Corticosteroid Receptor Status in the 21-Day Restraint Stress Paradigm Ann. N.Y. Acad. Sci., June 1, 2004; 1018(1): 323 - 327. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Obradovic, M. Tirard, Zs. Nemethy, O. Hirsch, H. Gronemeyer, and O. F. X. Almeida DAXX, FLASH, and FAF-1 Modulate Mineralocorticoid and Glucocorticoid Receptor-Mediated Transcription in Hippocampal Cells--Toward a Basis for the Opposite Actions Elicited by Two Nuclear Receptors? Mol. Pharmacol., March 1, 2004; 65(3): 761 - 769. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Hoijman, L. Rocha Viegas, M. I. Keller Sarmiento, R. E. Rosenstein, and A. Pecci Involvement of Bax Protein in the Prevention of Glucocorticoid-Induced Thymocytes Apoptosis by Melatonin Endocrinology, January 1, 2004; 145(1): 418 - 425. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Diem, M. Hobom, K. Maier, R. Weissert, M. K. Storch, R. Meyer, and M. Bahr Methylprednisolone Increases Neuronal Apoptosis during Autoimmune CNS Inflammation by Inhibition of an Endogenous Neuroprotective Pathway J. Neurosci., August 6, 2003; 23(18): 6993 - 7000. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Planey, A. Derfoul, A. Steplewski, N. M. Robertson, and G. Litwack Inhibition of Glucocorticoid-induced Apoptosis in 697 Pre-B Lymphocytes by the Mineralocorticoid Receptor N-terminal Domain J. Biol. Chem., October 25, 2002; 277(44): 42188 - 42196. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. CROCHEMORE, T. M. MICHAELIDIS, D. FISCHER, J.-P. LOEFFLER, and O. F. X. ALMEIDA Enhancement of p53 activity and inhibition of neural cell proliferation by glucocorticoid receptor activation FASEB J, June 1, 2002; 16(8): 761 - 770. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. DeVries, H.-D. Joh, O. Bernard, K. Hattori, P. D. Hurn, R. J. Traystman, and N. J. Alkayed Social stress exacerbates stroke outcome by suppressing Bcl-2 expression PNAS, September 5, 2001; (2001) 201215298. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. J. Northington, D. M. Ferriero, D. L. Flock, and L. J. Martin Delayed Neurodegeneration in Neonatal Rat Thalamus after Hypoxia-Ischemia Is Apoptosis J. Neurosci., March 15, 2001; 21(6): 1931 - 1938. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. DeVries, H.-D. Joh, O. Bernard, K. Hattori, P. D. Hurn, R. J. Traystman, and N. J. Alkayed Social stress exacerbates stroke outcome by suppressing Bcl-2 expression PNAS, September 25, 2001; 98(20): 11824 - 11828. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
